FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:192-194 January 15, 1998 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kawai, A. PubMed Citation

The study of chromosomal translocations in tumors has revealed much about the molecular biology of cancer.¹ The report by Kawai et al.² in this issue of the Journal highlights an important question: how useful to patient care are discoveries in the molecular biology of cancer? It also poses the longer-term question of how realistic it is to attempt to use this information to design effective therapies. Chromosomal translocations have been particularly well studied in hematopoietic tumors, which can easily be prepared for detailed cytogenetic studies.¹ Other types of tumors have also been studied, but with respect to solid tumors, consistent . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C.-J., Mueller, E., Spiegelman, B. M., Fletcher, J. A. (2000). PAX8-PPARgamma 1 Fusion in Oncogene Human Thyroid Carcinoma. Science 289: 1357-1360 [Abstract] [Full Text]  
• Visintin, M., Tse, E., Axelson, H., Rabbitts, T. H., Cattaneo, A. (1999). Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc. Natl. Acad. Sci. USA 96: 11723-11728 [Abstract] [Full Text]